| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT04237623 | GM-CSF With Post-Transplant Cyclophosphamide | Transplant-Related Hematologic Malignancy | Recruiting |
| NCT06828796 | Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic… | Hematologic Disease and Disorders | Recruiting |
| NCT02828592 | Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients… | Severe Aplastic Anemia | Recruiting |
| NCT05519579 | Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT05909059 | CAR T-cell Therapy in Patients With Renal Dysfunction | Non-hodgkin Lymphoma,B Cell | Recruiting |
| NCT06046248 | Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease | Chronic Graft Versus Host Disease | Recruiting |
| Phase 1 | |||
| NCT07511062 | Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML | Acute Myeloid Leukemia | Not Yet Recruiting |
| NCT07638982 | Axatilimab + CAR-T for High-Risk Lymphoma | Diffuse Large B Cell Lymphoma (DLBCL) | Not Yet Recruiting |
| Not specified | |||
| NCT05417971 | Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation | Hematologic Malignancy | Recruiting |